These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 8048054)
21. Monocrotaline pyrrole-induced pulmonary hypertension in fawn-hooded rats with platelet storage pool deficiency: 5-hydroxytryptamine uptake by isolated, perfused lungs. Hilliker KS; Bell TG; Roth RA Thromb Haemost; 1983 Dec; 50(4):844-7. PubMed ID: 6665765 [TBL] [Abstract][Full Text] [Related]
22. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo. Wang YP; Yan J; Beger RD; Fu PP; Chou MW Cancer Lett; 2005 Aug; 226(1):27-35. PubMed ID: 16004930 [TBL] [Abstract][Full Text] [Related]
23. Characterization of rat liver microsomal metabolites of clivorine, an hepatotoxic otonecine-type pyrrolizidine alkaloid. Lin G; Cui YY; Hawes EM Drug Metab Dispos; 2000 Dec; 28(12):1475-83. PubMed ID: 11095586 [TBL] [Abstract][Full Text] [Related]
24. The effect of the pyrrolizidine alkaloids, monocrotaline and trichodesmine, on tissue pyrrole binding and glutathione metabolism in the rat. Yan CC; Huxtable RJ Toxicon; 1995 May; 33(5):627-34. PubMed ID: 7660367 [TBL] [Abstract][Full Text] [Related]
25. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine. Xia Q; Yan J; Chou MW; Fu PP Toxicol Lett; 2008 May; 178(2):77-82. PubMed ID: 18395999 [TBL] [Abstract][Full Text] [Related]
26. Guinea pig and rat hepatic microsomal metabolism of monocrotaline. Dueker SR; Lamé MW; Morin D; Wilson DW; Segall HJ Drug Metab Dispos; 1992; 20(2):275-80. PubMed ID: 1352221 [TBL] [Abstract][Full Text] [Related]
27. Isolation and identification of a pyrrolic glutathione conjugate metabolite of the pyrrolizidine alkaloid monocrotaline. Lamé MW; Morin D; Jones AD; Segall HJ; Wilson DW Toxicol Lett; 1990 May; 51(3):321-9. PubMed ID: 2111054 [TBL] [Abstract][Full Text] [Related]
28. Metabolic activation of retronecine and retronecine N-oxide - formation of DHP-derived DNA adducts. Yan J; Xia Q; Chou MW; Fu PP Toxicol Ind Health; 2008 Apr; 24(3):181-8. PubMed ID: 18842697 [TBL] [Abstract][Full Text] [Related]
29. Characterization of hepatic DNA damage induced in rats by the pyrrolizidine alkaloid monocrotaline. Petry TW; Bowden GT; Huxtable RJ; Sipes IG Cancer Res; 1984 Apr; 44(4):1505-9. PubMed ID: 6423276 [TBL] [Abstract][Full Text] [Related]
30. Association of dehydromonocrotaline with rat red blood cells. Lamé MW; Jones AD; Morin D; Wilson DW; Segall HJ Chem Res Toxicol; 1997 Jun; 10(6):694-701. PubMed ID: 9208177 [TBL] [Abstract][Full Text] [Related]
31. Effects of monocrotaline and monocrotaline pyrrole on 5-hydroxytryptamine and paraquat uptake by lung slices. Hilliker KS; Garcia CM; Roth RA Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):179-97. PubMed ID: 6410470 [TBL] [Abstract][Full Text] [Related]
32. In vitro metabolism of isoline, a pyrrolizidine alkaloid from Ligularia duciformis, by rodent liver microsomal esterase and enhanced hepatotoxicity by esterase inhibitors. Tang J; Akao T; Nakamura N; Wang ZT; Takagawa K; Sasahara M; Hattori M Drug Metab Dispos; 2007 Oct; 35(10):1832-9. PubMed ID: 17639025 [TBL] [Abstract][Full Text] [Related]
33. Corticosteroid metabolism in isolated perfused rat liver and kidney. Experimental studies with emphasis on aldosterone. Egfjord M Acta Physiol Scand Suppl; 1995; 627():1-42. PubMed ID: 8848946 [TBL] [Abstract][Full Text] [Related]
34. [Relationship between the converting ability of liver microsomes and monocrotaline-induced pulmonary hypertension in male, female and castrated male rats]. Kiyatake K; Kakusaka I; Kasahara Y; Qi TM; Suzuki A; Nakano K; Kaneko N; Kitada M; Kuriyama T Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Feb; 32(2):125-9. PubMed ID: 8164398 [TBL] [Abstract][Full Text] [Related]
35. Hepatic metabolism and pulmonary toxicity of monocrotaline using isolated perfused liver and lung. Lafranconi WM; Huxtable RJ Biochem Pharmacol; 1984 Aug; 33(15):2479-84. PubMed ID: 6087830 [TBL] [Abstract][Full Text] [Related]
37. Comparative cytotoxicity of monocrotaline and its metabolites in cultured pulmonary artery endothelial cells. Taylor DW; Wilson DW; Lamé MW; Dunston SD; Jones AD; Segall HJ Toxicol Appl Pharmacol; 1997 Mar; 143(1):196-204. PubMed ID: 9073608 [TBL] [Abstract][Full Text] [Related]
38. ¹H NMR study of monocrotaline and its metabolites in human blood. Yang YC; Crowder J; Wardle NJ; Yang L; White KN; Wang ZT; Annie Bligh SW Food Chem Toxicol; 2011 Nov; 49(11):2793-9. PubMed ID: 21843583 [TBL] [Abstract][Full Text] [Related]
39. Lactate dehydrogenase activity and isozyme patterns in tissues and bronchoalveolar lavage fluid from rats treated with monocrotaline pyrrole. Schultze AE; Gunaga KP; Wagner JG; Hoorn CM; Moorehead WR; Roth RA Toxicol Appl Pharmacol; 1994 Jun; 126(2):301-10. PubMed ID: 8209383 [TBL] [Abstract][Full Text] [Related]
40. Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity. Yang M; Ruan J; Fu PP; Lin G Chem Biol Interact; 2016 Jan; 243():119-26. PubMed ID: 26365561 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]